Storebrand Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Sell
58,069
-111
-0.2% -$23K 0.03% 387
2026
Q1
$13.1M Sell
58,180
-872
-1% -$217K 0.04% 352
2025
Q4
$14.2M Hold
59,052
0.04% 335
2025
Q3
$16.2M Sell
59,052
-18,901
-24% -$5.16M 0.04% 312
2025
Q2
$20.1M Sell
77,953
-7,464
-9% -$1.78M 0.06% 292
2025
Q1
$19.1M Buy
85,417
+1,966
+2% +$459K 0.06% 285
2024
Q4
$19.1M Buy
83,451
+19,006
+29% +$4.58M 0.06% 296
2024
Q3
$15.7M Buy
64,445
+44,443
+222% +$9.93M 0.05% 321
2024
Q2
$3.83M Sell
20,002
-104
-0.5% -$21.1K 0.01% 526
2024
Q1
$3.98M Sell
20,106
-244
-1% -$44.7K 0.01% 534
2023
Q4
$3.5M Buy
20,350
+5,983
+42% +$919K 0.01% 563
2023
Q3
$2.12M Sell
14,367
-36,414
-72% -$6.58M 0.01% 604
2023
Q2
$11.1M Buy
50,781
+3,203
+7% +$714K 0.05% 355
2023
Q1
$10.4M Sell
47,578
-1,730
-4% -$375K 0.05% 356
2022
Q4
$10.3M Buy
49,308
+801
+2% +$176K 0.06% 344
2022
Q3
$10.6M Hold
48,507
0.06% 322
2022
Q2
$10.2M Sell
48,507
-2,744
-5% -$584K 0.06% 339
2022
Q1
$12.4M Sell
51,251
-5,416
-10% -$1.31M 0.06% 331
2021
Q4
$14.8M Sell
56,667
-741
-1% -$192K 0.07% 316
2021
Q3
$15.1M Sell
57,408
-149
-0.3% -$40.7K 0.07% 299
2021
Q2
$14.2M Sell
57,557
-5,529
-9% -$1.16M 0.07% 320
2021
Q1
$12.2M Buy
63,086
+180
+0.3% +$36.1K 0.07% 331
2020
Q4
$13.4M Buy
62,906
+635
+1% +$127K 0.08% 293
2020
Q3
$10.7M Buy
62,271
+5,284
+9% +$976K 0.08% 263
2020
Q2
$10.9M Buy
56,987
+4,935
+9% +$807K 0.09% 238
2020
Q1
$7.67M Buy
+52,052
New +$8.29M 0.08% 261

Other funds holding RMD

Storebrand Asset Management's RMD Position: Q2 2026 in Review

Storebrand Asset Management reduced its ResMed (RMD) stake by 0.19% in Q2 2026, selling an estimated $23K and leaving 58,069 shares worth $11.3M. The position accounts for 0.03% of the portfolio, ranked #387.

Storebrand Asset Management first reported a position in RMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $20.1M in Q2 2025. 836 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Storebrand Asset Management held 58,069 shares of ResMed worth $11.3M as of Q2 2026.
  • Storebrand Asset Management sold 111 ResMed shares in Q2 2026, an estimated $23K.
  • ResMed made up 0.03% of Storebrand Asset Management's portfolio in Q2 2026, its #387 holding.
  • Storebrand Asset Management first reported a position in ResMed in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's ResMed position peaked at $20.1M in Q2 2025.
  • 836 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.